Proteomics Market Sees 10.5% Growth as Solutions Gain Wider Acceptance

The global proteomics market size is projected to reach USD 94.7 billion by 2035.

Jul 2, 2025 - 15:04
 15
Proteomics Market Sees 10.5% Growth as Solutions Gain Wider Acceptance

Proteomics refers to the large-scale study of proteins and their interactions within the cell. It offers unparalleled insights into cellular processes, disease mechanisms, and potential therapeutic targets by mapping the complex protein networks and understanding their functions.

This process initially involves planning the proteomics experiment with respect to the research objective. This is followed by sample extraction, processing, and quantification. The data generated by mass spectrometry (MS) and other analytical tools requires sophisticated bioinformatics tools for analysis, generating reproduceable biological insights.

In the healthcare industry, this process is primarily used in personalized medicine, biomarker discovery and validation, as well as drug discovery and development. In addition, other industries, such as agriculture, food science, toxicology and astrobiology, are also benefiting from proteomics.

Given the numerous applications of protein study and advancement of several promising proteomics solutions, proteomics is anticipated to become one of the fastest growing markets within the pharmaceutical industry in the coming years.

According to Roots Analysis, the global proteomics market size is projected to reach USD 94.7 billion by 2035 from USD 31.6 billion in 2024, growing at a CAGR of 10.5% in the forecast period 2024-2035.

Proteomics Market Segments

Based on the type of offering, the market is segmented into kits and reagents, instruments / technologies and proteomics services.

The kits and reagents segment are likely to capture the largest share in the overall proteomics market, accounting for 75% in share 2024.

The proteomics services segment is expected to witness the highest market growth rate of 11.8%, annually, during the forecast period.

Based on the type of instrument / technology, the market is segmented into spectrometry, chromatography, electrophoresis, protein microarray, X-ray crystallography, surface plasmon resonance and other technologies.

The spectrometry segment is likely to capture the largest share in the overall proteomics market, accounting for 27% share in 2024.

The protein microarray segment is anticipated to witness the market growth rate of 11.9%, annually, during the forecast period.

Based on the type of reagent, the market is segmented into spectrometry reagents, chromatography reagents, electrophoresis reagents, protein microarray reagents, X-ray crystallography reagents, surface plasmon resonance reagents and other reagents.

The spectrometry reagent segment is likely to capture the largest share in the overall proteomics market, accounting for 27% share in 2024.

The protein microarray reagent segment is anticipated to witness a market growth rate of 11.3%, annually, during the forecast period.

Based on the type of proteomics service, the market is segmented into core proteomics services and bioinformatics services.

The core proteomics service segment is likely to capture the largest share in the overall proteomics market, accounting for 62% share in 2024.

The bioinformatics segment is expected to witness the highest market growth rate of 12.3%, annually, during the forecast period.

Based on the application area, the market is segmented into basic and translational research, diagnostics, drug discovery, and other application areas.

The diagnostics segment is likely to capture the largest share in the overall proteomics market, accounting for close to 45% in 2024.

The drug discovery segment is expected to witness the highest market growth rate of 8.6%, annually, during the forecast period.

Based on the end user, the market is segmented into academic and research institutes, clinical laboratories and hospitals, pharmaceutical and biotechnology companies and other end users.

The pharmaceutical and biotechnology companies segment is likely to capture the largest share in the overall proteomics market, accounting for close to 50% share in 2024.

The other end user segment, including service provider, is expected to witness the highest market growth rate of 11.2%, annually, during the forecast period.

Based on Regional Insights, the market is segmented into North America, Europe, and Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World

North America dominated the proteomics market and accounted for the largest revenue share of 42% in 2024.

In Latin America, and Middle East and North Africa, the proteomics market is anticipated to demonstrate a lucrative growth rate of 11.5%, annually, during the forecast period.

Key Players

Examples of key companies engaged in proteomics market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Agilent Technologies, Allele Life Sciences, Bertis, BGI Genomics, Bio - Rad Laboratories, Bruker, CellCarta, Creative Biolabs, Creative proteomics, Cytiva, Macrogen, Merck, Nautilus, Olink, Promega, Promise Proteomics, Proteome Factory, Proteome Sciences, Proteomics International, Revvity, SCIEX, Seer, SomaLogic, Thermo Fisher Scientific, VProteomics.

Regional Outlook

Based on the key geographical regions, the proteomics market can be segmented into six major regions, including North America, Europe, Asia Pacific, Latin America, Middle East and North Africa and rest of the world. Led by the US, North America is anticipated to capture most of the proteomics market in 2024.

The Asia Pacific is accounted to be the fastest-growing segment of the market. The growth of the manufacturing market in this region is primarily driven by technical advancements, the rise in skilled population, low labor costs and socio-economic regulatory reforms favoring the growth of the proteomics industry.

Key Report Takeaways

The current market landscape is highly fragmented, featuring the presence of both new entrants and established players; of these, more than 80% of the proteomics solution providers are small and mid-sized players

Stakeholders in this domain are engaged in offering a wide range of advanced instruments such as spectrometry and chromatography that can be used in core proteomics and bioinformatics

Considering the wide array of applications of proteomics and continuous research efforts of stakeholders in this domain, the adoption of proteomics solutions is poised to witness a steady growth in the foreseeable future

Currently, revenues generated by pharmaceutical and biotechnology companies are estimated to capture the largest market share (49%); further, proteomics market in China is likely to grow at a relatively faster pace

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the subject given. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way.

Contact Details

Gaurav Chaudhary

+1 (857) 387 7999
+44 (748) 188 1310

Email: sales@rootsanalysis.com